Alector (ALEC) Net Margin Growth (3y) (2021 - 2026)
Alector (ALEC) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn | 9,283.00 |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn | 6,537.00 |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn | 7,218.00 |
| 10 | Alector | 168.65 Mn | -37.87 Mn | - | -191,506.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -191,506.00 |
| Dec 31, 2025 | -23,175.00 |
| Sep 30, 2025 | -75,269.00 |
| Jun 30, 2025 | -40,003.00 |
| Mar 31, 2025 | -91,925.00 |
| Dec 31, 2024 | 33,904.00 |
| Sep 30, 2024 | -34,459.00 |
| Jun 30, 2024 | 58,321.00 |
| Mar 31, 2024 | 104,236.00 |
| Dec 31, 2023 | 301,977.00 |
| Sep 30, 2023 | 53,056.00 |
| Jun 30, 2023 | 447,327.00 |
| Mar 31, 2023 | 164,244.00 |
| Dec 31, 2022 | 17,587.00 |
| Sep 30, 2022 | 365,653.00 |
| Jun 30, 2022 | 112,189.00 |
| Mar 31, 2022 | 106,976.00 |
| Dec 31, 2021 | -13,492.00 |
| Sep 30, 2021 | 32,797.00 |
| Jun 30, 2021 | -66,758.00 |